Infinium Pharmachem (NSE:INFINIUM) ROCE % : 18.72% (As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Infinium Pharmachem ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Infinium Pharmachem's annualized ROCE % for the quarter that ended in Sep. 2024 was 18.72%.

Infinium Pharmachem ROCE % Historical Data

The historical data trend for Infinium Pharmachem's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Infinium Pharmachem ROCE % Chart

Infinium Pharmachem Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

ROCE %

21.91

40.72

49.67

51.30

33.56

Infinium Pharmachem Semi-Annual Data
	Mar20	Mar21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
ROCE %	Get a 7-Day Free Trial			55.43	39.66	38.16	23.40	18.72

Infinium Pharmachem ROCE % Calculation

Infinium Pharmachem's annualized ROCE % for the fiscal year that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	170.971	/	( ( (706.122 - 367.691)	+	(854.527 - 174.135) )	/ 2 )
	=	170.971	/	( (338.431	+	680.392)	/ 2 )
	=	170.971	/	509.4115
	=	33.56 %

Infinium Pharmachem's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Mar. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Mar. 2024 )		(Q: Sep. 2024 )
	=	160.888	/	( ( (854.527 - 174.135)	+	(1338.549 - 300.093) )	/ 2 )
	=	160.888	/	( ( 680.392	+	1038.456 )	/ 2 )
	=	160.888	/	859.424
	=	18.72 %

(1) Note: The EBIT data used here is two times the semi-annual (Sep. 2024) EBIT data.

Infinium Pharmachem (NSE:INFINIUM) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Infinium Pharmachem ROCE % Related Terms

Thank you for viewing the detailed overview of Infinium Pharmachem's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Infinium Pharmachem Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Infinium Pharmachem Ltd (NSE:INFINIUM) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

V.U. Nagar GIDC Road, Near Sardar Patel Statue, Suite 205, Sigma Prime, 2nd Floor, District Anand, Vallabh Vidhyanagar, GJ, IND, 388120

Website

https://infiniumpharmachem.com

Infinium Pharmachem Ltd is engaged in the business of manufacturing and supplying Iodine, Iodine Derivatives and Active Pharmaceutical Ingredients (APIs). It provides fully integrated customized services from R & D to Commercial scale manufacturing and packaging for its products to the Pharmaceutical, Agrochemical, Nutraceutical, Speciality Chemicals and various other chemicals Industries.

Infinium Pharmachem Headlines

No Headlines